; (ii) safety-related changes described in section 744L–1(a)(2)(C), required under section 505G(c)(5), or any other change the Secretary determines necessary to ensure safe use; or (iii) changes related to methods of testing safety or efficacy. (5) Listing of licensees, assignees, or successors in interest Requestors shall submit to the Secretary at the time when a final dosage form subject to such request is introduced or delivered for introduction into interstate commerce, a list of licensees, assignees, or successors in interest that have the exclusive right described in paragraph (1). (6) Human data defined For purposes of this subsection, the term human data means data from clinical trials of safety or effectiveness (including actual use studies), pharmacokinetics, or bioavailability. . (d) Sunscreen Innovation Act amendments Section 586C(e) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360fff–3(e) ) is amended by striking paragraph (3) and inserting the following: (3) Relationship to orders under section 505G A final sunscreen order shall be deemed to be a final administrative order under section 505G and subject to the applicable provisions under such section 505G, including with respect to amendment of such order. . (e) Preclusion of new sunscreen submissions